Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2025

Description

+ Include: 16 Videos (.mp4) + 16 Audios (.mp3) + 16 Subtitles (.vtt) + 16 PDFs, size: 13.43 GB

+ Target Audience: endocrinologists, rheumatologists, primary care providers

+ Sample video: contact me for sample video

+ Information:

1. Overview

The Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2025 provides an advanced clinical review of osteoporosis and metabolic bone diseases. The program focuses on evolving diagnostic tools, targeted therapeutic strategies, and managing complex cases, including atypical fractures, rare genetic bone disorders, and osteoporosis in specialized populations like men and premenopausal women.

Course Date: 2025

2. Learning Objectives

• Evaluate evolving definitions of osteoporosis and interpret complex DXA and Trabecular Bone Score (TBS) data to optimize patient assessment.

• Diagnose and manage rare and genetic bone diseases, including early-onset osteoporosis with WNT1 mutations and Vitamin D dependent rickets.

• Implement targeted screening and treatment approaches for underdiagnosed populations, specifically men and patients with anorexia nervosa.

• Formulate evidence-based management strategies for patients experiencing adverse events or atypical femur fractures during osteoporosis therapy.

• Assess the efficacy and safety considerations of parathyroid hormone analogs and other emerging therapeutics in bone health management.

3. Target Audience

Best for endocrinologists, rheumatologists, and primary care providers who want updates on osteoporosis management, DXA interpretation, and rare bone diseases.

4. Topics

1. 01 Lessons from 50 Years of Osteoporosis – Evolving Definitions, DEXA, and Treatment Strategies

2. 02 Early-Onset Osteoporosis With WNT1 Mutation – Genetic Diagnosis and Management

3. 03 PTHrP in Non-Malignant Hypercalcemia – What PTHrP Level Warrants Malignancy Workup

4. 04 Vitamin D Dependent Rickets Type 1A – Severe Complications from Delayed Treatment in a Pediatric Case

5. 05 Immune Checkpoint Inhibitors – Rare Case of Hypoparathyroidism in Metastatic Endometrial Cancer

6. 06 Osteoporosis in Men – Addressing Underdiagnosis, Targeted Screening, and Treatment Approaches

7. 07 Atypical Fractures During Denosumab Therapy in Osteoporosis – Management Dilemmas

8. 08 Osteoporosis With Atypical Femur Fracture – Navigating Postfracture Management Dilemmas

9. 09 Bone Health in Rural Patients – Navigating Therapy Choices for Osteoporosis and Paget Disease

10. 10 Rare Bone Diseases – 2025 Updates in Diagnosis and Emerging Therapeutics

11. 11 Adverse Events With Osteoporosis Therapies – Practical Strategies for Side Effect Management

12. 12 Anorexia Nervosa and Premenopausal Osteoporosis – Diagnostic and Management Challenges

13. 13 Osteoporosis Treatment Insights – Lessons from Bone Biopsy and Histomorphometry

14. 14 Parathyroid Hormone Analogs in Osteoporosis – Efficacy, Anabolic Window, and Safety Considerations

15. 15 Osteoporosis Assessment – Navigating DXA Quality, TBS, and Clinical Pitfalls

16. 16 Perioprosthetic Fractures in Osteoporotic Patients – Diagnosis, Management, and Prevention